Has Daniel Merenda, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,635 in general payments to Daniel Merenda, MD across 306 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Daniel Merenda, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Daniel Merenda, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Daniel Merenda, MD

Otolaryngology · Bridgeport, WVNPI 1265519680

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,561 of the $9,635 with a category attached, or 88.9%. 16 manufacturers reported payments, led by Aerin Medical Inc. at 57.3% of the total. Reporting peaked in 2023 at $2,617 and has fallen 59.4% since, to $1,062 in 2025. Among otolaryngology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,635in general payments, 2019–2025

Across 306 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aerin Medical Inc.$6K
Sanofi$1K
Acclarent, Inc$775
Smith+Nephew$456
Stryker$403
Regeneron Healthcare Solutions, Inc.$229
plus $1K from 10 others

What the payments were for

Consulting fees$1,07411%
Food & beverage$8,56189%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aerin Medical Inc.	206	$5,517
Sanofi	17	$1,224
Acclarent, Inc	28	$775
Smith+Nephew	6	$456
Stryker	12	$403
Regeneron Healthcare Solutions, Inc.	8	$229
Medtronic(2 entities)	10	$224
Intersect ENT, Inc.	3	$221
Integra Lifesciences Corporation	2	$163
Hologic Sales And Service, LLC	8	$132
ARS Pharmaceuticals Operations, Inc.	1	$121
E.r. Squibb & Sons, L.L.C.	1	$99
Merck	1	$31
Pacira Pharmaceuticals Incorporated	1	$14
GSK	1	$14
Sanofi-aventis U.S. LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,635 in reported general payments places this provider in the 95th percentile of 48 otolaryngology providers in West Virginia.

See all otolaryngology providers in West Virginia →

Medicare billing

Part B allowed, 2024

$59,430

Medicare patients

288

Services billed

1,517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	13	$48,637
Azelastine Hcl	204	$5,582
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	26	$3,307
Fluticasone Propionate	177	$3,141
Ipratropium Bromide	60	$1,818
Famotidine	173	$1,799
Mometasone Furoate	41	$1,518
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	81	$1,388
Pantoprazole Sodium	80	$846
Triamcinolone Acetonide	30	$834
Omeprazole	61	$783
Doxycycline Hyclate	25	$697
Montelukast Sodium	79	$629
Nystatin	21	$498
Mupirocin	46	$417

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Bridgeport

Kevin OxleyBridgeport$7K
Rusha PatelMorgantown$11K
Jenny CrossElkins$10K
Meghan TurnerMorgantown$9K
Jeffson ChungMorgantown$9K
Justin DouglasBeckley$4K
David BlaineBeckley$3K
Christopher TiuWheeling$3K
Patrick MaibergerMartinsburg$3K
John WadePoint Pleasant$2K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →